These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11124860)

  • 1. Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults.
    Tschöp M; Lahner H; Feldmeier H; Grasberger H; Morrison KM; Janssen OE; Attanasio AF; Strasburger CJ
    Eur J Endocrinol; 2000 Dec; 143(6):769-73. PubMed ID: 11124860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection.
    Lambert M; Zech F; De Nayer P; Jamez J; Vandercam B
    Am J Med; 1990 Dec; 89(6):748-51. PubMed ID: 2147539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum.
    Scriba PC; Bauer M; Emmert D; Fateh-Moghadam A; Hofmann GG; Horn K; Pickardt CR
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):629-43. PubMed ID: 115194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue.
    Glynn N; Halsall DJ; Boran G; Cook P; McDermott JH; Smith D; Tormey W; Thompson CJ; O'Gorman D; McKenna MJ; Agha A
    Growth Horm IGF Res; 2021; 57-58():101393. PubMed ID: 33971491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: effects on serum proteins and vaginal cytology.
    Cullberg G
    Contraception; 1984 Jul; 30(1):73-9. PubMed ID: 6236952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency.
    Giavoli C; Ferrante E; Ermetici F; Bergamaschi S; Ronchi CL; Lania AG; Ambrosi B; Spada A; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):717-21. PubMed ID: 17121521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations.
    Chung TT; Gunganah K; Monson JP; Drake WM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):496-500. PubMed ID: 26603673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M; Kanc K; Verhovec R; Kocijancic A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in serum concentrations of thyroxine-binding globulin and of cortisol-binding globulin after the induction of normal thyroid function in previously hyperthyroid patients.
    Vierhapper H; Nowotny P; Waldhäusl W
    Thyroid; 1999 Nov; 9(11):1085-7. PubMed ID: 10595456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of hormone-binding globulins in acute intermittent porphyria.
    Herrick AL; McColl KE; Wallace AM; Moore MR; Goldberg A
    Clin Chim Acta; 1990 Feb; 187(2):141-8. PubMed ID: 2107988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of various doses of biosynthetic growth hormone on levels of IGF-I binding protein 3 (IGFBP-3) in patients with hypopituitarism and growth hormone deficiency].
    Justová V; Lacinová Z; Marek J
    Sb Lek; 2002; 103(2):133-9. PubMed ID: 12688134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.